Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.10T
Market cap1.10T
Price-Earnings ratio
41.63
Price-Earnings ratio41.63
Dividend yield
0.56%
Dividend yield0.56%
Average volume
2.53M
Average volume2.53M
High today
$1,189.07
High today$1,189.07
Low today
$1,141.20
Low today$1,141.20
Open price
$1,162.27
Open price$1,162.27
Volume
1.34M
Volume1.34M
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,172.05. The company's market cap stands at 1.1T, with a P/E ratio of 41.63 and a dividend yield of 0.56%.

During the trading session on 2026-07-16, Eli Lilly(LLY) shares reached a daily high of $1,189.07 and a low of $1,141.20. At a current price of $1,172.05, the stock is +2.7% higher than the low and still -1.4% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 1.34M, versus its average volume of 2.53M.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

LLY News

Barchart 32m
Eli Lilly Is Buying AtaiBeckley in $2.8 Billion Deal. What It Means for LLY Stock - Barchart.com

...

Eli Lilly Is Buying AtaiBeckley in $2.8 Billion Deal. What It Means for LLY Stock - Barchart.com
TipRanks 1h
Lilly Quietly Expands Its Obesity Pipeline With New Early-Stage LY4174794 Trial

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...

TipRanks 1h
Lilly-Backed Gene Therapy Study Tracks Long Term Safety in Vestibular Schwannoma

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

TipRanks 1h
Eli Lilly Expands Obesity Pipeline With New Phase 1 Eloralintide Trial

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...

TipRanks 1h
Lilly’s Tersolisib Food-Effect Study Moves Forward, Adding Depth to Its Early-Stage Pipeline

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of...

TipRanks 3h
Why Is AtaiBeckley N.V. Stock Up Today?

AtaiBeckley N.V. (ATAI) stock surged on Thursday after the clinical-stage biopharmaceutical company announced an acquisition agreement with global pharmaceutica...

Nasdaq 4h
Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?

Key Points Johnson & Johnson maintains a diversified presence across innovative medicine and medical technology, generating significant cash flow. Eli Lilly i...

Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?
Nasdaq 4h
ATAI Stock Soars on Reports of Potential Acquisition by Eli Lilly

Shares of clinical-stage company AtaiBeckley ATAI surged 63.3% in after-hours trading on Wednesday after a Bloomberg report stated, citing people familiar with...

ATAI Stock Soars on Reports of Potential Acquisition by Eli Lilly
Investor's Business Daily 4h
Eli Lilly Trips Into Red-Hot Psychedelics Space With A Big Takeover

The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo? 7/16/2026 FDA advisors will debate the merits of seven peptides next week. The disc...

Eli Lilly Trips Into Red-Hot Psychedelics Space With A Big Takeover
The Wall Street Journal 6h
Eli Lilly to Buy AtaiBeckley for Initial $2.8 Billion

Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion. Scott Olson / Getty Images Eli Lilly LLY 0.35 %increase; up p...

Eli Lilly to Buy AtaiBeckley for Initial $2.8 Billion

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.